Loading...
Theophylline — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Theophylline
2025-Q4
Comprehensive analysis of India’s theophylline export trade — suppliers, buyers, prices, routes, and every shipment record.
104
Shipments
$645K
Trade Value
31
Suppliers
35
Buyers
26
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/theophylline
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s theophylline trade — 2025-Q4
KEY TAKEAWAY
Theophylline 2025-Q4 exports total $644.8K across 26 countries, with ADCOCK INGRAM LTD commanding 41.7% market share.
TOTAL SHIPMENTS
104
2025-Q4
EXPORT VALUE
$644.8K
FOB USD
TOTAL QUANTITY
2.1M
units shipped
INDIAN SUPPLIERS
31
unique exporters
GLOBAL BUYERS
35
unique importers
DESTINATIONS
26
countries
MEDIAN UNIT PRICE
$1.03
per unit
TOP-5 SHARE
91.6%
of total USD
BRANDED SHARE
73.1%
76 shipments
DOSAGE FORMS
9
product types
6 KEY FINDINGS
1
ADCOCK INGRAM LTD is India's #1 Theophylline exporter with $269.0K (41.7% market share).→ §5, Indian Supplier Rankings
2
Theophylline reached 26 countries, with United States as the top destination ($148.8K).→ §4, Global Destination Map
3
Market concentration is moderate (HHI: 2432) — top 10 suppliers control 99.3% of exports.→ §5, Indian Supplier Rankings
4
91.4% of buyers (32 of 35) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (76.9%) across 9 dosage forms.→ §7, Price Benchmarks
6
26 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 ADCOCK INGRAM LTD leads in volume — how do 30 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian theophylline exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Theophylline report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial theophylline trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian theophylline suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Theophylline India trade report
Product scope
Theophylline
All variants merged — branded and generic formulations of theophylline
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
104
Every commercial theophylline trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $150.3K, Nov $259.4K, Dec $235.1K. Shipment counts rose across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$150.3K
Oct USD
11 shipments
2
$259.4K
Nov USD
+72.6% MoM
3
$235.1K
Dec USD
-9.3% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov rose 72.6% in USD but shipment count kept climbing.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $150K, making it the weakest month by value.
Fig 3.2 Q4 cumulative USD reached $645K.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $109K rise in Nov, $24K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Trade grew steadily across the quarter.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $150K | 11 shipments |
| Nov | $259K | 59 shipments |
| Dec | $235K | 34 shipments |
| Q4 Total | $645K | 104 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Singapore held #1 throughout the quarter.
Fig 3.6 Top 10 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: ADCOCK INGRAM LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import theophylline from India, how much they buy, and who supplies each market
KEY TAKEAWAY
United States absorbs 23.1% of India’s 2025-Q4 theophylline trade ($148.8K). Beyond the top 10 destinations, 26 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Asia has 10 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 26 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much theophylline India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$333K
51.6% of trade
10 countries · 54 shipments
Europe
$8
0.0% of trade
1 countries · 6 shipments
Americas
$158K
24.6% of trade
7 countries · 20 shipments
Africa
$150K
23.3% of trade
7 countries · 19 shipments
Oceania
$3K
0.5% of trade
1 countries · 5 shipments
Fig 4.1 United States is the #1 corridor ($149K) — 26 flow arcs from India radiate across 5 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian theophylline it receives (light = low, dark = high). Orange arcs radiate from India to the top 26 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | United States | $149K | 10 | ALEMBIC PHARMACEUTICALS LTD | $114K | GLENMARK PHARMACEUTICALS LTD | $34K | WATSON PHARMA PVT LTD | $427 |
| 2 | Thailand | $148K | 2 | ADCOCK INGRAM LTD | $148K | — | — | — | — |
| 3 | Singapore | $110K | 13 | ADCOCK INGRAM LTD | $109K | SANITAS MEDTECH INSTITUTE PVT LTD | $613 | TULSI MEDICAL & GENERAL STORES | $1 |
| 4 | Nigeria | $74K | 2 | LIRICON TRADING PVT LTD | $74K | — | — | — | — |
| 5 | Sri Lanka | $66K | 8 | ZYDUS LIFESCIENCES LTD | $57K | ADCOCK INGRAM LTD | $9K | — | — |
| 6 | Niger | $54K | 3 | SOCOMED PHARMA PVT LTD | $54K | — | — | — | — |
| 7 | Sierra Leone | $19K | 3 | SOCOMED PHARMA PVT LTD | $19K | — | — | — | — |
| 8 | Venezuela | $10K | 2 | BHARAT PARENTERALS LTD | $8K | LARK LABORATORIES (INDIA) LTD | $2K | — | — |
| 9 | Turkey | $4K | 1 | VITALONE PHARMA PVT LTD | $4K | — | — | — | — |
| 10 | Australia | $3K | 5 | ADCOCK INGRAM LTD | $3K | TULSI MEDICAL & GENERAL STORES | $9 | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 51.6% of USD — but United States is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
23.1%
#1 country share
United States alone
84.7%
Top 5 share
5 of 26 countries
100.0%
Top 15 share
Long tail of 11 countries = 0.0%
HHI 1665
Destination HHI
Moderately concentrated
26
Countries served
Global pharma reach from India
10
Asia countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
31 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
ADCOCK INGRAM LTD ($269.0K, 41.7% share) and ALEMBIC PHARMACEUTICALS LTD ($114.3K) together control 59.4% of India’s 2025-Q4 theophylline trade. The top 5 suppliers hold 91.6%. 31 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian theophylline suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 ADCOCK INGRAM LTD leads by $155K over ALEMBIC PHARMACEUTICALS LTD — top 20 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: MOVID IMPEX is #19 by value but #5 by volume.
Fig 5.2 ADCOCK INGRAM LTD also leads by shipment count (15) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: MOVID IMPEX moves from #5 by volume to #19 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 31 theophylline suppliers split into strategic segments
KEY TAKEAWAY
8 suppliers (25%) generate 98.7% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 ADCOCK INGRAM LTD and ALEMBIC PHARMACEUTICALS LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 98.7% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LTD | 3 | 2 | $60K |
| 2 | DERRIC WOOD | 2 | 1 | $1K |
| 3 | ADCOCK INGRAM LTD | 1 | 4 | $269K |
| 4 | ALEMBIC PHARMACEUTICALS LTD | 1 | 1 | $114K |
| 5 | SOCOMED PHARMA PVT LTD | 1 | 2 | $73K |
| 6 | GLENMARK PHARMACEUTICALS LTD | 1 | 1 | $34K |
| 7 | BHARAT PARENTERALS LTD | 1 | 1 | $8K |
| 8 | VITALONE PHARMA PVT LTD | 1 | 1 | $4K |
| 9 | JMBS HEALTHCARE | 1 | 1 | $2K |
| 10 | YASH PHARMA LABORATORIES PVT LTD | 1 | 1 | $2K |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the theophylline manufacturing hubs
KEY TAKEAWAY
Bangalore and Gujarat together account for $353K of India’s 2025-Q4 theophylline trade.
Fig 5.5 Bangalore (3 exporters, $239K) and Gujarat (1 exporters, $114K) are India’s theophylline capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
91.6%
Top 5 share
5 of 31 suppliers
99.3%
Top 10 share
10 of 31 suppliers
98.7%
Top 25% share
8 suppliers = 99% USD
HHI 2432
Supplier HHI
Moderate
31
Total suppliers
shipped Theophylline in 2025-Q4
20+ cities
Indian hubs
Bangalore and Gujarat lead
§5.2 Coming next: 4 exporter deep-dive profiles
Each of the top 4 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | ADCOCK INGRAM LTD | $269K |
| #2 | SOCOMED PHARMA PVT LTD | $73K |
| #3 | ZYDUS LIFESCIENCES LTD | $60K |
| #4 | TULSI MEDICAL & GENERAL STORES | $18 |
#1
EXPORTER PROFILE #1 OF 4
ADCOCK INGRAM LTD
Bangalore · India’s #1 theophylline supplier by USD · 2025-Q4
2025-Q4 USD
$269K
41.7% market share
SHIPMENTS
15
avg $18K/ship
COUNTRIES
4
destination markets
BUYERS
5
4 single-sourced
BRANDED
47%
of shipments
DOSAGE FORMS
1
product types
TOP 4 DESTINATIONS
Thailand is the #1 market at $148K (55% of trade), followed by Singapore at $109K. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Thailand | $148K | 2 | 54.9% |
| 2 | Singapore | $109K | 11 | 40.5% |
| 3 | Sri Lanka | $9K | 1 | 3.4% |
| 4 | Australia | $3K | 1 | 1.3% |
MONTHLY TREND
Dec was the strongest month, ending the quarter on a high at $196K.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 4/4 LOCKED IN
4 of 4 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| INOVA PHARMA (THAILAND… | Thailand | $148K | ⚠ Locked |
| INOVA PHARMACEUTICALS … | Singapore | $78K | ⚠ Locked |
| Undisclosed buyer | Singapore | $30K | N/A |
| A BAUR & CO PVT LTD | Sri Lanka | $9K | ⚠ Locked |
| INOVA PHARMACEUTICALS … | Australia | $3K | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 4 — TRADE FLOW MAP
ADCOCK INGRAM LTD — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P1.3 Thailand absorbs $148K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 2 importers per destination.
#4
EXPORTER PROFILE #2 OF 4
SOCOMED PHARMA PVT LTD
15 · India’s #4 theophylline supplier by USD · 2025-Q4
2025-Q4 USD
$73K
11.3% market share
SHIPMENTS
6
avg $12K/ship
COUNTRIES
2
destination markets
BUYERS
5
4 single-sourced
BRANDED
17%
of shipments
DOSAGE FORMS
1
product types
TOP 2 DESTINATIONS
Niger is the #1 market at $54K (74% of trade), followed by Sierra Leone at $19K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Niger | $54K | 3 | 74.1% |
| 2 | Sierra Leone | $19K | 3 | 25.9% |
MONTHLY TREND
Nov peaked at $56K. Dec was the weakest at $0.
PRODUCT MIX
Tablet dominates at 83% of trade. Unknown (17.0%) and others are secondary formulations.
TOP BUYERS · 4/4 LOCKED IN
4 of 4 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| SOUMAILA SOULEY WAHABOU | Niger | $22K | ⚠ Locked |
| Undisclosed buyer | Niger | $22K | N/A |
| PEOPLES ENTERPRISESFRE… | Sierra Leone | $17K | ⚠ Locked |
| ETS BOUBACAR AMADOU MA… | Niger | $11K | ⚠ Locked |
| PEOPLES ENTERPRISES CO… | Sierra Leone | $2K | ⚠ Locked |
#4
EXPORTER PROFILE #2 OF 4 — TRADE FLOW MAP
SOCOMED PHARMA PVT LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P2.3 Niger absorbs $54K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 3 importers per destination.
#5
EXPORTER PROFILE #3 OF 4
ZYDUS LIFESCIENCES LTD
Ahmedabad/Gujrat · India’s #5 theophylline supplier by USD · 2025-Q4
2025-Q4 USD
$60K
9.4% market share
SHIPMENTS
8
avg $8K/ship
COUNTRIES
2
destination markets
BUYERS
2
2 single-sourced
BRANDED
63%
of shipments
DOSAGE FORMS
3
product types
TOP 2 DESTINATIONS
Sri Lanka is the #1 market at $57K (95% of trade), followed by Kenya at $3K. 2 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Sri Lanka | $57K | 7 | 95.1% |
| 2 | Kenya | $3K | 1 | 4.9% |
MONTHLY TREND
Nov peaked at $56K. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 87% of trade. retard (7.9%) and Syrup are secondary formulations.
TOP BUYERS · 2/2 LOCKED IN
2 of 2 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| SUNSHINE HEALTHCARE LA… | Sri Lanka | $57K | ⚠ Locked |
| RIPPLE PHARMACEUTICALS… | Kenya | $3K | ⚠ Locked |
#5
EXPORTER PROFILE #3 OF 4 — TRADE FLOW MAP
ZYDUS LIFESCIENCES LTD — Supplier → Country → Importer
2 destination countries, top 5 importers per country
Fig 5.P3.3 Sri Lanka absorbs $57K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 2 destinations and up to 1 importers per destination.
#22
EXPORTER PROFILE #4 OF 4
TULSI MEDICAL & GENERAL STORES
Mumbai · India’s #22 theophylline supplier by USD · 2025-Q4
2025-Q4 USD
$18
0.0% market share
SHIPMENTS
13
avg $1/ship
COUNTRIES
4
destination markets
BUYERS
2
unique importers
BRANDED
69%
of shipments
DOSAGE FORMS
2
product types
TOP 4 DESTINATIONS
Australia is the #1 market at $9 (50% of trade), followed by United States at $5. 4 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Australia | $9 | 4 | 49.8% |
| 2 | United States | $5 | 4 | 24.7% |
| 3 | Netherlands | $3 | 4 | 17.7% |
| 4 | Singapore | $1 | 1 | 7.8% |
MONTHLY TREND
Nov peaked at $17. Oct was the weakest at $0.
PRODUCT MIX
Injection dominates at 69% of trade. Tablet (23.3%) and Unknown are secondary formulations.
TOP BUYERS · 0 BUYERS
Buyers are well-diversified across multiple Indian suppliers.
| Buyer | Country | USD | Status |
|---|---|---|---|
| Undisclosed buyer | Australia | $14 | N/A |
| Undisclosed buyer | Australia | $5 | N/A |
#22
EXPORTER PROFILE #4 OF 4 — TRADE FLOW MAP
TULSI MEDICAL & GENERAL STORES — Supplier → Country → Importer
4 destination countries, top 5 importers per country
Fig 5.P4.3 Australia absorbs $9 — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 4 destinations and up to 2 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
35 importers across 26 countries — who is buying Indian theophylline and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 25 importers together hold only 91.6% of total USD. 91% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian theophylline. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 INOVA PHARMA (THAILAND) CO LTD is the #1 importer at $148K (22.9%) — top 25 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 25 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
91%
Single-source
32 buyers rely on exactly 1 Indian supplier
3%
Dual-source
1 buyers use 2 Indian suppliers
3%
Multi-source (3–4)
1 buyers diversified across 3–4
3%
Broad-source (5+)
1 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source theophylline from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
United States 3 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| J. KNIPPER & COMPANY | ALEMBIC PHARMACEUTIC… | $114K | $0.074 | Tablet |
| GLENMARK PHARMACEUTICA… | GLENMARK PHARMACEUTI… | $34K | $32.348 | Tablet |
| TEVA PHARMACEUTICALS U… | WATSON PHARMA PVT LTD | $426.969 | $0.154 | Tablet |
Singapore 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| INOVA PHARMACEUTICALS … | ADCOCK INGRAM LTD | $78K | $1.736 | Tablet |
| SUCCESS INTER LINK PTE… | SANITAS MEDTECH INST… | $612.942 | $30.647 | Tablet |
Sri Lanka 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| SUNSHINE HEALTHCARE LA… | ZYDUS LIFESCIENCES LTD | $57K | $2.498 | retard |
| A BAUR & CO PVT LTD | ADCOCK INGRAM LTD | $9K | $1.682 | Tablet |
Niger 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| SOUMAILA SOULEY WAHABOU | SOCOMED PHARMA PVT LTD | $22K | $0.361 | Tablet |
| ETS BOUBACAR AMADOU MA… | SOCOMED PHARMA PVT LTD | $11K | $0.361 | — |
Sierra Leone 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| PEOPLES ENTERPRISESFRE… | SOCOMED PHARMA PVT LTD | $17K | $0.355 | Tablet |
| PEOPLES ENTERPRISES CO… | SOCOMED PHARMA PVT LTD | $2K | $0.357 | — |
§6.3 Price positioning — top 25 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | INOVA PHARMA (THAILA… | Thailand | $148K | $74K | Premium |
| 2 | J. KNIPPER & COMPANY | United States | $114K | $114K | Premium |
| 3 | INOVA PHARMACEUTICAL… | Singapore | $78K | $13K | Budget |
| 4 | MORELIFE PHARMACY AN… | Nigeria | $74K | $37K | Premium |
| 5 | SUNSHINE HEALTHCARE … | Sri Lanka | $57K | $8K | Budget |
| 6 | GLENMARK PHARMACEUTI… | United States | $34K | $11K | Budget |
| 7 | SOUMAILA SOULEY WAHA… | Niger | $22K | $22K | Mid |
| 8 | PEOPLES ENTERPRISESF… | Sierra Leone | $17K | $9K | Budget |
| 9 | ETS BOUBACAR AMADOU … | Niger | $11K | $11K | Budget |
| 10 | A BAUR & CO PVT LTD | Sri Lanka | $9K | $9K | Budget |
| 11 | LABORATORIOS ZUZU, C… | Venezuela | $8K | $8K | Budget |
| 12 | ROZ LOJISTIK ULUSLAR… | Turkey | $4K | $4K | Budget |
| 13 | INOVA PHARMACEUTICAL… | Australia | $3K | $3K | Budget |
| 14 | RIPPLE PHARMACEUTICA… | Kenya | $3K | $3K | Budget |
| 15 | UTL PHARMACY PVT LTD | Nepal | $2K | $2K | Budget |
| 16 | PEOPLES ENTERPRISES … | Sierra Leone | $2K | $2K | Budget |
| 17 | LABORATORIOS BUKA C.A | Venezuela | $2K | $2K | Budget |
| 18 | EMIRATES POST COMPANY | United Arab Emirates | $1K | $76.000 | Budget |
| 19 | SUCCESS INTER LINK P… | Singapore | $612.942 | $613.000 | Budget |
| 20 | TEVA PHARMACEUTICALS… | United States | $426.969 | $213.000 | Budget |
| 21 | ELTON TATENDA GUWU | South Africa | $257.509 | $258.000 | Budget |
| 22 | REGENCY EXIM TRADE LTD | Mauritius | $28.515 | $14.000 | Budget |
| 23 | EMIRATES POST GROUP | United Arab Emirates | $22.468 | $6.000 | Budget |
| 24 | SEQUENCE MEDICARE SD… | Malaysia | $22.165 | $11.000 | Budget |
| 25 | HEALTH CITY CAYMAN I… | Cayman Islands | $19.758 | $20.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 20 × 20 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 ADCOCK INGRAM LTD → INOVA PHARMA (THAILAND) CO LTD is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 20 Indian suppliers; right = top 20 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian theophylline prices vary by supplier, country and dosage form
KEY TAKEAWAY
Theophylline prices span 7708× ($0.0042 → $32.58). The coefficient of variation is 2.28. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0042 | Lowest observed unit price |
| P5 | $0.062 | 5th percentile |
| P25 | $0.216 | 25th percentile (Q1) |
| Median | $1.03 | 50th percentile (Q2) |
| P75 | $2.73 | 75th percentile (Q3) |
| P95 | $17.19 | 95th percentile |
| Max | $32.58 | Highest observed unit price |
| Mean | $2.98 | Arithmetic average |
| CV | 228% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 GLENMARK PHARMACEUTICALS LTD prices at $32.22/unit vs market median $1.03.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. SOCOMED PHARMA PVT Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. ADCOCK INGRAM LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. e.g. ALEMBIC PHARMACEUTICALS LTD Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. e.g. VITALONE PHARMA PVT Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | GLENMARK PHARMAC… | United States | Tablet | 211 | $7K | $32.58 | Specialty / small-batch |
| Dec 2025 | GLENMARK PHARMAC… | United States | Tablet | 629 | $20K | $32.55 | Specialty / small-batch |
| Dec 2025 | GLENMARK PHARMAC… | United States | Tablet | 214 | $7K | $31.53 | Specialty / small-batch |
| Nov 2025 | SANITAS MEDTECH … | Singapore | Tablet | 20 | $612.94 | $30.65 | Specialty / small-batch |
| Nov 2025 | SAVA HEALTHCARE … | Mauritius | Tablet | 1 | $28.20 | $28.20 | Specialty / small-batch |
| Nov 2025 | JMBS HEALTHCARE | Lebanon | Raw Material | 125 | $2K | $15.97 | Specialty / small-batch |
| Nov 2025 | ADCOCK INGRAM LTD | Singapore | Tablet | 2K | $9K | $5.29 | Specialty / small-batch |
| Nov 2025 | ADCOCK INGRAM LTD | Singapore | Tablet | 2K | $9K | $5.29 | Specialty / small-batch |
| Nov 2025 | HANSI TRADERS | South Africa | Injection | 67 | $257.51 | $3.84 | Sterile formulation premium |
| Nov 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 18 | $68.66 | $3.81 | Specialty / small-batch |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | AASHIRWAD PHARMA… | Dominica | retard tablet | 100 | $0.423 | $0.0042 | Bulk generic tablet |
| Dec 2025 | NALIINI.R.EXPORT… | Seychelles | retard capsule | 20 | $0.159 | $0.0080 | Small sample / trial shipment |
| Dec 2025 | MOVID IMPEX | United Arab Emirates | Tablet | 2 | $0.057 | $0.029 | Small sample / trial shipment |
| Dec 2025 | MOVID IMPEX | United Arab Emirates | Tablet | 7 | $0.200 | $0.029 | Small sample / trial shipment |
| Dec 2025 | DERRIC WOOD | United Arab Emirates | Tablet | 18 | $0.662 | $0.037 | Small sample / trial shipment |
| Dec 2025 | DISTINCT IMPEX P… | Iraq | Tablet | 50 | $3.25 | $0.065 | Small sample / trial shipment |
| Dec 2025 | DISTINCT IMPEX P… | Iraq | Tablet | 50 | $3.25 | $0.065 | Small sample / trial shipment |
| Oct 2025 | ALEMBIC PHARMACE… | United States | Tablet | 1.5M | $114K | $0.074 | Bulk volume discount |
| Oct 2025 | MEDICARE PHARMA | Maldives | Tablet | 60 | $7.73 | $0.129 | Small sample / trial shipment |
| Oct 2025 | BHARAT PARENTERA… | Venezuela | Tablet | 56K | $8K | $0.143 |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship theophylline, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Theophylline leaves India through 11+ ports. The top 5 (BANGALORE ICD, NHAVA SHEVA SEA (JNPT), MUNDRA SEA) handle 98.5% of total USD. SEA moves 20% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 BANGALORE ICD handles $260K — top 11 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 BANGKOK is the #1 global destination port — top 25 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
SEA dominates at 20% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
SEA
$331K
51.3% of USD · 20.2% of ships
ICD
$261K
40.6% of USD · 14.4% of ships
AIR
$51K
7.8% of USD · 64.4% of ships
ROAD
$2K
0.3% of USD · 1.0% of ships
Fig 8.3 The dominant corridor is BANGALORE ICD → Sea → Asia ($257K).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Sierra Leone is the most concentrated destination (HHI 10000, 1 suppliers). Seychelles is the most competitive (HHI 4391).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Sierra Leone (HHI 10,000) is the most concentrated — Seychelles (HHI 4,391) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 20 of 20 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| INOVA PHARMA (THAILA… | Thailand | ADCOCK INGRAM LTD | $148K | 2 | HIGH |
| J. KNIPPER & COMPANY | United States | ALEMBIC PHARMACE… | $114K | 1 | HIGH |
| INOVA PHARMACEUTICAL… | Singapore | ADCOCK INGRAM LTD | $78K | 6 | MEDIUM |
| MORELIFE PHARMACY AN… | Nigeria | LIRICON TRADING … | $74K | 2 | MEDIUM |
| SUNSHINE HEALTHCARE … | Sri Lanka | ZYDUS LIFESCIENC… | $57K | 7 | MEDIUM |
| GLENMARK PHARMACEUTI… | United States | GLENMARK PHARMAC… | $34K | 3 | MEDIUM |
| SOUMAILA SOULEY WAHA… | Niger | SOCOMED PHARMA P… | $22K | 1 | MEDIUM |
| PEOPLES ENTERPRISESF… | Sierra Leone | SOCOMED PHARMA P… | $17K | 2 | MEDIUM |
Conclusion: 32 buyers depend on exactly one Indian supplier, representing $591K in trade. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| United States | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Thailand | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Singapore | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nigeria | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Sri Lanka | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Niger | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Sierra Leone | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Venezuela | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Turkey | Tier 3 (emerging) | 14–28 days (sea) | $0.10–$1/unit | LOW | First-mover advantage |
| Australia | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Lebanon | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Nepal | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| United Arab Emirates | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| South Africa | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 14 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Thailand | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Sierra Leone lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter United States (4 suppliers) | This Q | HIGH |
| A6 | Enter Thailand (1 suppliers) | This Q | MED |
| A8 | Build Thailand distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (ZYDUS LIFESCIENCES) | This Q | MED |
| A7 | Register for United States tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | United States | Other | 4 | $149K | -69.8% | LOW | Low competition (4 suppliers), accessible market |
| 2 | Thailand | Asia | 1 | $148K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Singapore | Asia | 3 | $110K | 0% | LOW | Low competition (3 suppliers), accessible market |
| 4 | Nigeria | Africa | 1 | $74K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | Sri Lanka | Asia | 2 | $66K | -47.2% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Niger | Africa | 1 | $54K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Sierra Leone | Africa | 1 | $19K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Venezuela | Other | 2 | $10K | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Turkey | Other | 1 | $4K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Australia | Other | 2 | $3K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Kenya | Africa | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Lebanon | Other | 1 | $2K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Nepal | Asia | 1 | $2K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | United Arab Emirates | Other | 2 | $1K | 0% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Seychelles | Africa | 3 | $70 | +394.8% | LOW | Growing 395% with only 3 competitors |
This report covers 104 2025-Q4 Theophylline shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/theophylline
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 104 2025-Q4 theophylline shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian theophylline shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
104
across all regions
TOTAL USD
$645K
2025-Q4 FOB value
UNITS
2.1M
tablets, capsules, etc.
SUPPLIERS
31
Indian exporters
BUYERS
35
global importers
COUNTRIES
26
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $150K (23.3%), spanning 7 countries.
31 Indian suppliers shipped to 35 buyers across 26 countries — average shipment value $6K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
7 countries · 19 shipments · $150K · 8 Indian suppliers · 12 buyers
SHIPMENTS
19
USD
$150K
COUNTRIES
7
SUPPLIERS
8
BUYERS
12
HHI
4,785
concentrated
Top 7 destination countries in Africa
1
Nigeria (49.1%)
$74K
2
Niger (36.0%)
$54K
3
Sierra Leone (12.6%)
$19K
4
Kenya (2.0%)
$3K
5
South Africa (0.2%)
$257.51
6
Seychelles (0.0%)
$69.66
7
Mauritius (0.0%)
$28.51
Top 8 Indian suppliers into Africa
1
LIRICON TRADING PVT LTD
$74K
2
SOCOMED PHARMA PVT LTD
$73K
3
ZYDUS LIFESCIENCES LTD
$3K
4
HANSI TRADERS
$257.51
5
CAPSTONE EXPORT & IMPORT
$41.12
6
SAVA HEALTHCARE LTD
$28.51
7
CHEMSELECT PVT LTD
$18.33
8
NALIINI.R.EXPORT PVT LTD
$10.22
Top 10 Africa importers
1
MORELIFE PHARMACY AND GENERAL MERCH · Nigeria
$74K
2
SOUMAILA SOULEY WAHABOU · Niger
$22K
3
PEOPLES ENTERPRISESFREETOWN, SIERRA · Sierra Leone
$17K
4
ETS BOUBACAR AMADOU MAMODOU · Niger
$11K
5
RIPPLE PHARMACEUTICALS LTD · Kenya
$3K
6
PEOPLES ENTERPRISES CO LTD · Sierra Leone
$2K
7
ELTON TATENDA GUWU · South Africa
$257.51
8
REGENCY EXIM TRADE LTD · Mauritius
$28.51
9
CAREWELL PHARMACY (PTY)LTD · Seychelles
$18.33
10
CENTRAL POINT PHARMACY · Seychelles
$10.22
Top 7 dosage forms
1
Unknown
$86K
2
Tablet
$61K
3
Syrup
$3K
4
Injection
$257.51
5
retard capsule
$11.89
6
retard
$8.63
7
Other
$1.43
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $17K | $6K |
| Nov | 11 | $133K | $12K |
| Dec | 5 | $43.02 | $8.60 |
Shipment register · 19 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — LIRICON TRADING PVT LTD · 2 shipments · $74K | |||||||||||
| 1 | Nov 2025 | MORELIFE PHARMACY AND GENERAL MERCH | Nigeria | 41.5K | NOS | $1.03 | $43K | NHAVA SHEVA SEA (JNPT) | Apapa | SEA | |
| 2 | Nov 2025 | MORELIFE PHARMACY AND GENERAL MERCH | Nigeria | 13.0K | NOS | $2.40 | $31K | NHAVA SHEVA SEA (JNPT) | Apapa | SEA | |
| SUPPLIER #2 — SOCOMED PHARMA PVT LTD · 6 shipments · $73K | |||||||||||
| 3 | Oct 2025 | PEOPLES ENTERPRISESFREETOWN, SIERRA | Sierra Leone | Tablet | 8.4K | NOS | $0.363 | $3K | NHAVA SHEVA SEA (JNPT) | Freetown | SEA |
| 4 | Oct 2025 | PEOPLES ENTERPRISESFREETOWN, SIERRA | Sierra Leone | Tablet | 40.5K | PCS | $0.354 | $14K | NHAVA SHEVA SEA (JNPT) | Freetown | SEA |
| 5 | Nov 2025 | SOUMAILA SOULEY WAHABOU | Niger | Tablet | 60.0K | PCS | $0.361 | $22K | NHAVA SHEVA SEA (JNPT) | Tema | SEA |
| 6 | Nov 2025 | UNKNOWN BUYER | Niger | Tablet | 60.0K | PCS | $0.361 | $22K | NHAVA SHEVA SEA (JNPT) | Tema | SEA |
| 7 | Nov 2025 | PEOPLES ENTERPRISES CO LTD | Sierra Leone | 4.5K | PCS | $0.357 | $2K | NHAVA SHEVA SEA (JNPT) | Freetown | SEA | |
| 8 | Nov 2025 | ETS BOUBACAR AMADOU MAMODOU | Niger | 30.0K | PCS | $0.361 | $11K | NHAVA SHEVA SEA (JNPT) | Tema | SEA | |
| SUPPLIER #3 — ZYDUS LIFESCIENCES LTD · 1 shipments · $3K | |||||||||||
| 9 | Nov 2025 | RIPPLE PHARMACEUTICALS LTD | Kenya | Syrup | 2.5K | NOS | $1.18 | $3K | AHMEDABAD AIR | NAIROBI | AIR |
| SUPPLIER #4 — HANSI TRADERS · 1 shipments · $257.51 | |||||||||||
| 10 | Nov 2025 | ELTON TATENDA GUWU | South Africa | Injection | 67 | PCS | $3.84 | $257.51 | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| SUPPLIER #5 — CAPSTONE EXPORT & IMPORT · 2 shipments · $41.12 | |||||||||||
| 11 | Dec 2025 | UNLISTED BUYER | Seychelles | Tablet | 100 | NOS | $0.230 | $23.01 | CHENNAI AIR | MAHE ISLAND | AIR |
| 12 | Dec 2025 | UNLISTED BUYER | Seychelles | Tablet | 85 | NOS | $0.213 | $18.11 | CHENNAI AIR | MAHE ISLAND | AIR |
| SUPPLIER #6 — SAVA HEALTHCARE LTD · 2 shipments · $28.51 | |||||||||||
| 13 | Nov 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 1 | NOS | $28.20 | $28.20 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| 14 | Dec 2025 | REGENCY EXIM TRADE LTD | Mauritius | Tablet | 1 | NOS | $0.319 | $0.319 | MUMBAI AIR (SAHAR) | MAURITIUS | AIR |
| SUPPLIER #7 — CHEMSELECT PVT LTD · 2 shipments · $18.33 | |||||||||||
| 15 | Nov 2025 | CAREWELL PHARMACY (PTY)LTD | Seychelles | retard capsule | 30 | NOS | $0.391 | $11.73 | COCHIN AIR | MAHE ISLAND | AIR |
| 16 | Nov 2025 | CAREWELL PHARMACY (PTY)LTD | Seychelles | Tablet | 30 | NOS | $0.220 | $6.60 | COCHIN AIR | MAHE ISLAND | AIR |
| SUPPLIER #8 — NALIINI.R.EXPORT PVT LTD · 3 shipments · $10.22 | |||||||||||
| 17 | Oct 2025 | CENTRAL POINT PHARMACY | Seychelles | retard | 13 | NOS | $0.664 | $8.63 | CHENNAI AIR | MAHE ISLAND | AIR |
| 18 | Dec 2025 | CENTRAL POINT PHARMACY | Seychelles | retard capsule | 20 | NOS | $0.0080 | $0.159 | CHENNAI AIR | MAHE ISLAND | AIR |
| 19 | Dec 2025 | CENTRAL POINT PHARMACY | Seychelles | Other | 2 | NOS | $0.714 | $1.43 | CHENNAI AIR | MAHE ISLAND | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
10 countries · 54 shipments · $333K · 14 Indian suppliers · 13 buyers
SHIPMENTS
54
USD
$333K
COUNTRIES
10
SUPPLIERS
14
BUYERS
13
HHI
6,675
concentrated
Top 10 destination countries in Asia
1
Thailand (44.4%)
$148K
2
Singapore (32.9%)
$110K
3
Sri Lanka (20.0%)
$66K
4
Turkey (1.2%)
$4K
5
Lebanon (0.6%)
$2K
6
Nepal (0.6%)
$2K
7
United Arab Emirates (0.3%)
$1K
8
Maldives (0.0%)
$70.16
9
Malaysia (0.0%)
$22.17
10
Iraq (0.0%)
$6.49
Top 14 Indian suppliers into Asia
1
ADCOCK INGRAM LTD
$266K
2
ZYDUS LIFESCIENCES LTD
$57K
3
VITALONE PHARMA PVT LTD
$4K
4
JMBS HEALTHCARE
$2K
5
YASH PHARMA LABORATORIES PVT LTD
$2K
6
DERRIC WOOD
$1K
7
SANITAS MEDTECH INSTITUTE PVT LTD
$612.94
8
HEMS ( INDIA )
$59.79
9
MOVID IMPEX
$22.47
10
MERCURY MEDICARE
$22.17
11
MEDICARE PHARMA
$7.73
12
DISTINCT IMPEX PVT LTD
$6.49
13
MC PHARMA DISTRIBUTORS
$2.64
14
TULSI MEDICAL & GENERAL STORES
$1.43
Top 11 Asia importers
1
INOVA PHARMA (THAILAND) CO LTD · Thailand
$148K
2
INOVA PHARMACEUTICALS (SINGAPORE) · Singapore
$78K
3
SUNSHINE HEALTHCARE LANKA LTD · Sri Lanka
$57K
4
A BAUR & CO PVT LTD · Sri Lanka
$9K
5
ROZ LOJISTIK ULUSLARARASI TASIMACIL · Turkey
$4K
6
UTL PHARMACY PVT LTD · Nepal
$2K
7
EMIRATES POST COMPANY · United Arab Emirates
$1K
8
SUCCESS INTER LINK PTE LTD · Singapore
$612.94
9
EMIRATES POST GROUP · United Arab Emirates
$22.47
10
SEQUENCE MEDICARE SDN BHD · Malaysia
$22.17
11
TREE TOP HEALTH PVT LTD · Maldives
$10.37
Top 6 dosage forms
1
Tablet
$273K
2
Injection
$53K
3
retard
$5K
4
Raw Material
$2K
5
Capsule
$122.91
6
Syrup
$2.64
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 5 | $9K | $2K |
| Nov | 31 | $123K | $4K |
| Dec | 18 | $201K | $11K |
Shipment register · 54 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ADCOCK INGRAM LTD · 14 shipments · $266K | |||||||||||
| 1 | Oct 2025 | A BAUR & CO PVT LTD | Sri Lanka | Tablet | 5.4K | NOS | $1.68 | $9K | BANGALORE AIR | COLOMBO | AIR |
| 2 | Nov 2025 | INOVA PHARMACEUTICALS (SINGAPORE) | Singapore | Tablet | 6.0K | NOS | $1.61 | $10K | BANGALORE ICD | Singapore | ICD |
| 3 | Nov 2025 | INOVA PHARMACEUTICALS (SINGAPORE) | Singapore | Tablet | 635 | NOS | $1.61 | $1K | BANGALORE ICD | Singapore | ICD |
| 4 | Nov 2025 | INOVA PHARMACEUTICALS (SINGAPORE) | Singapore | Tablet | 4.9K | NOS | $1.15 | $6K | BANGALORE ICD | Singapore | ICD |
| 5 | Nov 2025 | INOVA PHARMACEUTICALS (SINGAPORE) | Singapore | Tablet | 1.8K | NOS | $5.29 | $9K | BANGALORE ICD | Singapore | ICD |
| 6 | Nov 2025 | INOVA PHARMACEUTICALS (SINGAPORE) | Singapore | Tablet | 2.9K | NOS | $1.61 | $5K | BANGALORE ICD | Singapore | ICD |
| 7 | Nov 2025 | UNKNOWN BUYER | Singapore | Tablet | 6.0K | NOS | $1.61 | $10K | BANGALORE ICD | Singapore | ICD |
| 8 | Nov 2025 | UNKNOWN BUYER | Singapore | Tablet | 635 | NOS | $1.61 | $1K | BANGALORE ICD | Singapore | ICD |
| 9 | Nov 2025 | UNKNOWN BUYER | Singapore | Tablet | 4.9K | NOS | $1.15 | $6K | BANGALORE ICD | Singapore | ICD |
| 10 | Nov 2025 | UNKNOWN BUYER | Singapore | Tablet | 1.8K | NOS | $5.29 | $9K | BANGALORE ICD | Singapore | ICD |
| 11 | Nov 2025 | UNKNOWN BUYER | Singapore | Tablet | 2.9K | NOS | $1.61 | $5K | BANGALORE ICD | Singapore | ICD |
| 12 | Dec 2025 | INOVA PHARMA (THAILAND) CO LTD | Thailand | Tablet | 102.2K | NOS | $1.42 | $146K | BANGALORE ICD | BANGKOK | ICD |
| 13 | Dec 2025 | INOVA PHARMA (THAILAND) CO LTD | Thailand | Tablet | 1.4K | NOS | $1.42 | $2K | BANGALORE ICD | BANGKOK | ICD |
| 14 | Dec 2025 | INOVA PHARMACEUTICALS (SINGAPORE) | Singapore | Tablet | 29.0K | NOS | $1.66 | $48K | BANGALORE ICD | SINGAPORE | ICD |
| SUPPLIER #2 — ZYDUS LIFESCIENCES LTD · 7 shipments · $57K | |||||||||||
| 15 | Oct 2025 | SUNSHINE HEALTHCARE LANKA LTD | Sri Lanka | retard | 240 | PCS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 16 | Nov 2025 | SUNSHINE HEALTHCARE LANKA LTD | Sri Lanka | Injection | 13.3K | PCS | $3.07 | $41K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 17 | Nov 2025 | SUNSHINE HEALTHCARE LANKA LTD | Sri Lanka | Injection | 5.9K | PCS | $1.97 | $12K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 18 | Nov 2025 | SUNSHINE HEALTHCARE LANKA LTD | Sri Lanka | Injection | 661 | PCS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 19 | Nov 2025 | SUNSHINE HEALTHCARE LANKA LTD | Sri Lanka | Injection | 325 | PCS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 20 | Dec 2025 | SUNSHINE HEALTHCARE LANKA LTD | Sri Lanka | retard | 2.4K | PCS | $2.01 | $5K | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| 21 | Dec 2025 | SUNSHINE HEALTHCARE LANKA LTD | Sri Lanka | retard | 130 | PCS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Colombo | SEA |
| SUPPLIER #3 — VITALONE PHARMA PVT LTD · 1 shipments · $4K | |||||||||||
| 22 | Nov 2025 | ROZ LOJISTIK ULUSLARARASI TASIMACIL | Turkey | Tablet | 5.2K | NOS | $0.763 | $4K | NHAVA SHEVA SEA (JNPT) | Mersin | SEA |
| SUPPLIER #4 — JMBS HEALTHCARE · 1 shipments · $2K | |||||||||||
| 23 | Nov 2025 | UNKNOWN BUYER | Lebanon | Raw Material | 125 | NOS | $15.97 | $2K | DELHI AIR | BEIRUT | AIR |
| SUPPLIER #5 — YASH PHARMA LABORATORIES PVT LTD · 1 shipments · $2K | |||||||||||
| 24 | Nov 2025 | UTL PHARMACY PVT LTD | Nepal | Tablet | 817 | NOS | $2.28 | $2K | RAXAUL | Birgunj | ROAD |
| SUPPLIER #6 — DERRIC WOOD · 15 shipments · $1K | |||||||||||
| 25 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $3.81 | $68.66 | DELHI AIR | DUBAI | AIR |
| 26 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $3.01 | $54.25 | DELHI AIR | DUBAI | AIR |
| 27 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $3.81 | $68.61 | DELHI AIR | DUBAI | AIR |
| 28 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 36 | PCS | $3.01 | $108.33 | DELHI AIR | DUBAI | AIR |
| 29 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $3.81 | $68.61 | DELHI AIR | DUBAI | AIR |
| 30 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 36 | PCS | $3.01 | $108.33 | DELHI AIR | DUBAI | AIR |
| 31 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 18 | PCS | $3.81 | $68.66 | DELHI AIR | DUBAI | AIR |
| 32 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Capsule | 18 | PCS | $3.01 | $54.25 | DELHI AIR | DUBAI | AIR |
| 33 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $2.99 | $53.87 | DELHI AIR | DUBAI | AIR |
| 34 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $3.79 | $68.23 | DELHI AIR | DUBAI | AIR |
| 35 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $3.79 | $68.23 | DELHI AIR | DUBAI | AIR |
| 36 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 48 | PCS | $3.00 | $144.01 | DELHI AIR | DUBAI | AIR |
| 37 | Nov 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 48 | PCS | $3.02 | $145.01 | DELHI AIR | DUBAI | AIR |
| 38 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $3.01 | $54.15 | DELHI AIR | DUBAI | AIR |
| 39 | Dec 2025 | EMIRATES POST COMPANY | United Arab Emirates | Tablet | 18 | PCS | $0.037 | $0.662 | DELHI AIR | DUBAI | AIR |
| SUPPLIER #7 — SANITAS MEDTECH INSTITUTE PVT LTD · 1 shipments · $612.94 | |||||||||||
| 40 | Nov 2025 | SUCCESS INTER LINK PTE LTD | Singapore | Tablet | 20 | NOS | $30.65 | $612.94 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
| SUPPLIER #8 — HEMS ( INDIA ) · 2 shipments · $59.79 | |||||||||||
| 41 | Oct 2025 | UNLISTED BUYER | Maldives | Tablet | 90 | NOS | $0.332 | $29.90 | CHENNAI AIR | MALE | AIR |
| 42 | Oct 2025 | UNLISTED BUYER | Maldives | Tablet | 90 | NOS | $0.332 | $29.90 | CHENNAI AIR | MALE | AIR |
| SUPPLIER #9 — MOVID IMPEX · 4 shipments · $22.47 | |||||||||||
| 43 | Dec 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 2 | NOS | $2.47 | $4.94 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 44 | Dec 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 7 | NOS | $2.47 | $17.28 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 45 | Dec 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 2 | NOS | $0.029 | $0.057 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| 46 | Dec 2025 | EMIRATES POST GROUP | United Arab Emirates | Tablet | 7 | NOS | $0.029 | $0.200 | MUMBAI AIR (SAHAR) | DUBAI | AIR |
| SUPPLIER #10 — MERCURY MEDICARE · 2 shipments · $22.17 | |||||||||||
| 47 | Dec 2025 | SEQUENCE MEDICARE SDN BHD | Malaysia | Tablet | 59 | NOS | $0.185 | $10.90 | COCHIN AIR | KUALA LUMPUR - INT'L | AIR |
| 48 | Dec 2025 | SEQUENCE MEDICARE SDN BHD | Malaysia | Tablet | 61 | NOS | $0.185 | $11.26 | COCHIN AIR | KUALA LUMPUR - INT'L | AIR |
| SUPPLIER #11 — MEDICARE PHARMA · 1 shipments · $7.73 | |||||||||||
| 49 | Oct 2025 | TREE TOP HEALTH PVT LTD | Maldives | Tablet | 60 | PCS | $0.129 | $7.73 | CHENNAI AIR | MALE | AIR |
| SUPPLIER #12 — DISTINCT IMPEX PVT LTD · 2 shipments · $6.49 | |||||||||||
| 50 | Dec 2025 | UNLISTED BUYER | Iraq | Tablet | 50 | NOS | $0.065 | $3.25 | MUMBAI AIR (SAHAR) | Erbil Inter airport | AIR |
| 51 | Dec 2025 | UNLISTED BUYER | Iraq | Tablet | 50 | NOS | $0.065 | $3.25 | MUMBAI AIR (SAHAR) | Erbil Inter airport | AIR |
| SUPPLIER #13 — MC PHARMA DISTRIBUTORS · 2 shipments · $2.64 | |||||||||||
| 52 | Dec 2025 | TREE TOP HEALTH PVT LTD | Maldives | Syrup | 2 | PCS | $0.660 | $1.32 | CHENNAI AIR | MALE | AIR |
| 53 | Dec 2025 | TREE TOP HEALTH PVT LTD | Maldives | Syrup | 2 | PCS | $0.660 | $1.32 | CHENNAI AIR | MALE | AIR |
| SUPPLIER #14 — TULSI MEDICAL & GENERAL STORES · 1 shipments · $1.43 | |||||||||||
| 54 | Dec 2025 | UNLISTED BUYER | Singapore | Tablet | 4 | NOS | $0.358 | $1.43 | MUMBAI AIR (SAHAR) | SINGAPORE | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
1 countries · 6 shipments · $8.23 · 2 Indian suppliers · 3 buyers
SHIPMENTS
6
USD
$8.23
COUNTRIES
1
SUPPLIERS
2
BUYERS
3
HHI
5,213
concentrated
Top 1 destination countries in Europe
1
Netherlands (100.0%)
$8.23
Top 2 Indian suppliers into Europe
1
3CUBE MEDICARE PVT LTD
$4.96
2
TULSI MEDICAL & GENERAL STORES
$3.26
Top 2 Europe importers
1
THE MASTER OF X PRESS GODAVARI · Netherlands
$2.68
2
THE MASTER OF X PRESS MULHACEN · Netherlands
$2.28
Top 2 dosage forms
1
Tablet
$4.96
2
Injection
$3.26
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 5 | $5.54 | $1.11 |
| Dec | 1 | $2.68 | $2.68 |
Shipment register · 6 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — 3CUBE MEDICARE PVT LTD · 2 shipments · $4.96 | |||||||||||
| 1 | Nov 2025 | THE MASTER OF X PRESS MULHACEN | Netherlands | Tablet | 1 | NOS | $2.28 | $2.28 | MUMBAI AIR (SAHAR) | ROTTERDAM | AIR |
| 2 | Dec 2025 | THE MASTER OF X PRESS GODAVARI | Netherlands | Tablet | 2 | NOS | $1.34 | $2.68 | MUMBAI AIR (SAHAR) | ROTTERDAM | AIR |
| SUPPLIER #2 — TULSI MEDICAL & GENERAL STORES · 4 shipments · $3.26 | |||||||||||
| 3 | Nov 2025 | UNLISTED BUYER | Netherlands | Injection | 3 | NOS | $0.163 | $0.490 | MUMBAI AIR (SAHAR) | AMSTERDAM, SCHIPHOL | AIR |
| 4 | Nov 2025 | UNLISTED BUYER | Netherlands | Injection | 3 | NOS | $0.163 | $0.490 | MUMBAI AIR (SAHAR) | AMSTERDAM, SCHIPHOL | AIR |
| 5 | Nov 2025 | UNLISTED BUYER | Netherlands | Injection | 7 | NOS | $0.163 | $1.14 | MUMBAI AIR (SAHAR) | AMSTERDAM, SCHIPHOL | AIR |
| 6 | Nov 2025 | UNLISTED BUYER | Netherlands | Injection | 7 | NOS | $0.163 | $1.14 | MUMBAI AIR (SAHAR) | AMSTERDAM, SCHIPHOL | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
7 countries · 20 shipments · $158K · 11 Indian suppliers · 10 buyers
SHIPMENTS
20
USD
$158K
COUNTRIES
7
SUPPLIERS
11
BUYERS
10
HHI
5,698
concentrated
Top 7 destination countries in Americas
1
United States (94.0%)
$149K
2
Venezuela (6.0%)
$10K
3
Cayman Islands (0.0%)
$19.76
4
Canada (0.0%)
$4.79
5
Panama (0.0%)
$3.11
6
Guyana (0.0%)
$1.59
7
Dominica (0.0%)
$0.423
Top 11 Indian suppliers into Americas
1
ALEMBIC PHARMACEUTICALS LTD
$114K
2
GLENMARK PHARMACEUTICALS LTD
$34K
3
BHARAT PARENTERALS LTD
$8K
4
LARK LABORATORIES (INDIA) LTD
$2K
5
WATSON PHARMA PVT LTD
$426.97
6
NARAYANA HRUDAYALAYA LTD
$19.76
7
APOTEX RESEARCH PVT LTD
$4.79
8
TULSI MEDICAL & GENERAL STORES
$4.55
9
3CUBE MEDICARE PVT LTD
$3.11
10
PEAK HEALTHCARE
$1.59
11
AASHIRWAD PHARMA INTERNATIONAL PVT LTD
$0.423
Top 9 Americas importers
1
J. KNIPPER & COMPANY · United States
$114K
2
GLENMARK PHARMACEUTICALS INC · United States
$34K
3
LABORATORIOS ZUZU, CA.CALLE MATURIN · Venezuela
$8K
4
LABORATORIOS BUKA C.A · Venezuela
$2K
5
TEVA PHARMACEUTICALS USA INC · United States
$426.97
6
HEALTH CITY CAYMAN ISLANDS (HCCI) · Cayman Islands
$19.76
7
APOTEX INC · Canada
$4.79
8
THE MASTER OF ECO TRAMONTANE · Panama
$3.11
9
BULLSEYE PHARMACY · Dominica
$0.423
Top 3 dosage forms
1
Tablet
$158K
2
Injection
$3.12
3
retard tablet
$0.423
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $124K | $41K |
| Nov | 7 | $9.34 | $1.33 |
| Dec | 10 | $35K | $3K |
Shipment register · 20 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ALEMBIC PHARMACEUTICALS LTD · 1 shipments · $114K | |||||||||||
| 1 | Oct 2025 | J. KNIPPER & COMPANY | United States | Tablet | 1.5M | TBS | $0.074 | $114K | MUNDRA SEA | NORFOLK | SEA |
| SUPPLIER #2 — GLENMARK PHARMACEUTICALS LTD · 3 shipments · $34K | |||||||||||
| 2 | Dec 2025 | GLENMARK PHARMACEUTICALS INC | United States | Tablet | 211 | THD | $32.58 | $7K | MUMBAI AIR (SAHAR) | NEW YORK | AIR |
| 3 | Dec 2025 | GLENMARK PHARMACEUTICALS INC | United States | Tablet | 629 | THD | $32.55 | $20K | MUMBAI AIR (SAHAR) | NEW YORK | AIR |
| 4 | Dec 2025 | GLENMARK PHARMACEUTICALS INC | United States | Tablet | 214 | THD | $31.53 | $7K | MUMBAI AIR (SAHAR) | NEW YORK - JOHN F. K | AIR |
| SUPPLIER #3 — BHARAT PARENTERALS LTD · 1 shipments · $8K | |||||||||||
| 5 | Oct 2025 | LABORATORIOS ZUZU, CA.CALLE MATURIN | Venezuela | Tablet | 55.8K | NOS | $0.143 | $8K | NHAVA SHEVA SEA (JNPT) | La Guaira | SEA |
| SUPPLIER #4 — LARK LABORATORIES (INDIA) LTD · 1 shipments · $2K | |||||||||||
| 6 | Oct 2025 | LABORATORIOS BUKA C.A | Venezuela | Tablet | 9.9K | NOS | $0.156 | $2K | DADRI ICD | LA GUAIRA | ICD |
| SUPPLIER #5 — WATSON PHARMA PVT LTD · 2 shipments · $426.97 | |||||||||||
| 7 | Dec 2025 | TEVA PHARMACEUTICALS USA INC | United States | Tablet | 1.4K | NOS | $0.154 | $213.25 | MUMBAI AIR (SAHAR) | NEW YORK - JOHN F. K | AIR |
| 8 | Dec 2025 | TEVA PHARMACEUTICALS USA INC | United States | Tablet | 1.4K | NOS | $0.154 | $213.71 | MUMBAI AIR (SAHAR) | NEW YORK - JOHN F. K | AIR |
| SUPPLIER #6 — NARAYANA HRUDAYALAYA LTD · 1 shipments · $19.76 | |||||||||||
| 9 | Dec 2025 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | Tablet | 30 | NOS | $0.659 | $19.76 | BANGALORE AIR | GEORGETOWN | AIR |
| SUPPLIER #7 — APOTEX RESEARCH PVT LTD · 3 shipments · $4.79 | |||||||||||
| 10 | Nov 2025 | APOTEX INC | Canada | Tablet | 1 | NOS | $1.60 | $1.60 | BANGALORE AIR | TORONTO | AIR |
| 11 | Nov 2025 | APOTEX INC | Canada | Tablet | 1 | NOS | $1.20 | $1.20 | BANGALORE AIR | TORONTO | AIR |
| 12 | Nov 2025 | APOTEX INC | Canada | Tablet | 2 | NOS | $0.998 | $2.00 | BANGALORE AIR | TORONTO | AIR |
| SUPPLIER #8 — TULSI MEDICAL & GENERAL STORES · 4 shipments · $4.55 | |||||||||||
| 13 | Nov 2025 | UNLISTED BUYER | United States | Tablet | 4 | NOS | $0.357 | $1.43 | MUMBAI AIR (SAHAR) | HOUSTON, INTERCONTIN | AIR |
| 14 | Nov 2025 | UNLISTED BUYER | United States | Injection | 1 | NOS | $0.156 | $0.156 | MUMBAI AIR (SAHAR) | HOUSTON, INTERCONTIN | AIR |
| 15 | Nov 2025 | UNLISTED BUYER | United States | Injection | 1 | NOS | $0.156 | $0.156 | MUMBAI AIR (SAHAR) | HOUSTON, INTERCONTIN | AIR |
| 16 | Nov 2025 | UNLISTED BUYER | United States | Injection | 18 | NOS | $0.156 | $2.81 | MUMBAI AIR (SAHAR) | HOUSTON, INTERCONTIN | AIR |
| SUPPLIER #9 — 3CUBE MEDICARE PVT LTD · 1 shipments · $3.11 | |||||||||||
| 17 | Dec 2025 | THE MASTER OF ECO TRAMONTANE | Panama | Tablet | 1 | NOS | $3.11 | $3.11 | MUMBAI AIR (SAHAR) | PANAMA CITY - | AIR |
| SUPPLIER #10 — PEAK HEALTHCARE · 2 shipments · $1.59 | |||||||||||
| 18 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 7 | NOS | $0.0000 | $0.0000 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| 19 | Dec 2025 | UNLISTED BUYER | Guyana | Tablet | 7 | NOS | $0.227 | $1.59 | NHAVA SHEVA SEA (JNPT) | Georgetown | SEA |
| SUPPLIER #11 — AASHIRWAD PHARMA INTERNATIONAL PVT LTD · 1 shipments · $0.423 | |||||||||||
| 20 | Dec 2025 | BULLSEYE PHARMACY | Dominica | retard tablet | 100 | NOS | $0.0042 | $0.423 | MUMBAI AIR (SAHAR) | YEOSU | AIR |
10
PART VI — DRILL-DOWN · OCEANIA
Region: Oceania
1 countries · 5 shipments · $3K · 2 Indian suppliers · 3 buyers
SHIPMENTS
5
USD
$3K
COUNTRIES
1
SUPPLIERS
2
BUYERS
3
HHI
9,946
concentrated
Top 1 destination countries in Oceania
1
Australia (100.0%)
$3K
Top 2 Indian suppliers into Oceania
1
ADCOCK INGRAM LTD
$3K
2
TULSI MEDICAL & GENERAL STORES
$9.16
Top 1 Oceania importers
1
INOVA PHARMACEUTICALS (AUSTRALIA) · Australia
$3K
Top 3 dosage forms
1
Tablet
$3K
2
Injection
$6.31
3
Unknown
$1.43
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 0 | $0.0000 | — |
| Nov | 5 | $3K | $680.33 |
| Dec | 0 | $0.0000 | — |
Shipment register · 5 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ADCOCK INGRAM LTD · 1 shipments · $3K | |||||||||||
| 1 | Nov 2025 | INOVA PHARMACEUTICALS (AUSTRALIA) | Australia | Tablet | 1.9K | NOS | $1.80 | $3K | BANGALORE ICD | Sydney | ICD |
| SUPPLIER #2 — TULSI MEDICAL & GENERAL STORES · 4 shipments · $9.16 | |||||||||||
| 2 | Nov 2025 | UNLISTED BUYER | Australia | Tablet | 4 | NOS | $0.357 | $1.43 | MUMBAI AIR (SAHAR) | MELBOURNE | AIR |
| 3 | Nov 2025 | UNLISTED BUYER | Australia | Injection | 20 | NOS | $0.158 | $3.15 | MUMBAI AIR (SAHAR) | MELBOURNE | AIR |
| 4 | Nov 2025 | UNKNOWN BUYER | Australia | 4 | NOS | $0.357 | $1.43 | MUMBAI AIR (SAHAR) | MELBOURNE | AIR | |
| 5 | Nov 2025 | UNKNOWN BUYER | Australia | Injection | 20 | NOS | $0.158 | $3.15 | MUMBAI AIR (SAHAR) | MELBOURNE | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 31 Indian theophylline exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped theophylline in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | ADCOCK INGRAM LTD | BANGALORE | 15 | $269K | Tablet | Asia, Oceania |
| 2 | ALEMBIC PHARMACEUTICALS LTD | GUJARAT | 1 | $114K | Tablet | Americas |
| 3 | LIRICON TRADING PVT LTD | KANDIVALI EAST | 2 | $74K | Africa | |
| 4 | SOCOMED PHARMA PVT LTD | 15 | 6 | $73K | Tablet | Africa |
| 5 | ZYDUS LIFESCIENCES LTD | AHMEDABAD/GUJRAT | 8 | $60K | retard, Injection, Syrup | Asia, Africa |
| 6 | GLENMARK PHARMACEUTICALS LTD | GOA | 3 | $34K | Tablet | Americas |
| 7 | BHARAT PARENTERALS LTD | DIST.VADODARA | 1 | $8K | Tablet | Americas |
| 8 | VITALONE PHARMA PVT LTD | MUMBAI | 1 | $4K | Tablet | Asia |
| 9 | JMBS HEALTHCARE | NEAR PREET PALACE | 1 | $2K | Raw Material | Asia |
| 10 | YASH PHARMA LABORATORIES PVT LTD | BHAGWANPUR | 1 | $2K | Tablet | Asia |
| 11 | LARK LABORATORIES (INDIA) LTD | NEW DELHI | 1 | $2K | Tablet | Americas |
| 12 | DERRIC WOOD | SUBHASH PLACE | 15 | $1K | Tablet, Capsule | Asia |
| 13 | SANITAS MEDTECH INSTITUTE PVT LTD | Narhen | 1 | $612.94 | Tablet | Asia |
| 14 | WATSON PHARMA PVT LTD | GOA | 2 | $426.97 | Tablet | Americas |
| 15 | HANSI TRADERS | ANKLESHWAR | 1 | $257.51 | Injection | Africa |
| 16 | HEMS ( INDIA ) | CHENNAI | 2 | $59.79 | Tablet | Asia |
| 17 | CAPSTONE EXPORT & IMPORT | CHENNAI | 2 | $41.12 | Tablet | Africa |
| 18 | SAVA HEALTHCARE LTD | PUNE | 2 | $28.51 | Tablet | Africa |
| 19 | MOVID IMPEX | MUMBAI | 4 | $22.47 | Tablet | Asia |
| 20 | MERCURY MEDICARE | CHENNAI | 2 | $22.17 | Tablet | Asia |
| 21 | NARAYANA HRUDAYALAYA LTD | BANGALORE | 1 | $19.76 | Tablet | Americas |
| 22 | TULSI MEDICAL & GENERAL STORES | MUMBAI | 13 | $18.41 | Tablet, Injection | Oceania, Americas |
| 23 | CHEMSELECT PVT LTD | THIRUVANANTHAPURAM | 2 | $18.33 | retard capsule, Tablet | Africa |
| 24 | NALIINI.R.EXPORT PVT LTD | CHENNAI | 3 | $10.22 | retard, retard capsule, Other | Africa |
| 25 | 3CUBE MEDICARE PVT LTD | Mumbai | 3 | $8.07 | Tablet | Europe, Americas |
| 26 | MEDICARE PHARMA | CHENNAI | 1 | $7.73 | Tablet | Asia |
| 27 | DISTINCT IMPEX PVT LTD | MUMBAI | 2 | $6.49 | Tablet | Asia |
| 28 | APOTEX RESEARCH PVT LTD | BANGALORE | 3 | $4.79 | Tablet | Americas |
| 29 | MC PHARMA DISTRIBUTORS | CHENNAI | 2 | $2.64 | Syrup | Asia |
| 30 | PEAK HEALTHCARE | MUMBAI | 2 | $1.59 | Tablet | Americas |
| 31 | AASHIRWAD PHARMA INTERNATIONAL PVT LTD | PUNE | 1 | $0.423 | retard tablet | Americas |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 33 global theophylline importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian theophylline in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | INOVA PHARMA (THAILAND) CO LTD | Thailand | 2 | $148K | ADCOCK INGRAM LTD | Tablet |
| 2 | J. KNIPPER & COMPANY | United States | 1 | $114K | ALEMBIC PHARMACEUTIC… | Tablet |
| 3 | INOVA PHARMACEUTICALS (SINGAPORE) | Singapore | 6 | $78K | ADCOCK INGRAM LTD | Tablet |
| 4 | MORELIFE PHARMACY AND GENERAL MERCH | Nigeria | 2 | $74K | LIRICON TRADING PVT … | |
| 5 | SUNSHINE HEALTHCARE LANKA LTD | Sri Lanka | 7 | $57K | ZYDUS LIFESCIENCES LTD | retard, Injection |
| 6 | GLENMARK PHARMACEUTICALS INC | United States | 3 | $34K | GLENMARK PHARMACEUTI… | Tablet |
| 7 | SOUMAILA SOULEY WAHABOU | Niger | 1 | $22K | SOCOMED PHARMA PVT LTD | Tablet |
| 8 | PEOPLES ENTERPRISESFREETOWN, SIERRA | Sierra Leone | 2 | $17K | SOCOMED PHARMA PVT LTD | Tablet |
| 9 | ETS BOUBACAR AMADOU MAMODOU | Niger | 1 | $11K | SOCOMED PHARMA PVT LTD | |
| 10 | A BAUR & CO PVT LTD | Sri Lanka | 1 | $9K | ADCOCK INGRAM LTD | Tablet |
| 11 | LABORATORIOS ZUZU, CA.CALLE MATURIN | Venezuela | 1 | $8K | BHARAT PARENTERALS LTD | Tablet |
| 12 | ROZ LOJISTIK ULUSLARARASI TASIMACIL | Turkey | 1 | $4K | VITALONE PHARMA PVT … | Tablet |
| 13 | INOVA PHARMACEUTICALS (AUSTRALIA) | Australia | 1 | $3K | ADCOCK INGRAM LTD | Tablet |
| 14 | RIPPLE PHARMACEUTICALS LTD | Kenya | 1 | $3K | ZYDUS LIFESCIENCES LTD | Syrup |
| 15 | UTL PHARMACY PVT LTD | Nepal | 1 | $2K | YASH PHARMA LABORATO… | Tablet |
| 16 | PEOPLES ENTERPRISES CO LTD | Sierra Leone | 1 | $2K | SOCOMED PHARMA PVT LTD | |
| 17 | LABORATORIOS BUKA C.A | Venezuela | 1 | $2K | LARK LABORATORIES (I… | Tablet |
| 18 | EMIRATES POST COMPANY | United Arab Emirates | 15 | $1K | DERRIC WOOD | Tablet, Capsule |
| 19 | SUCCESS INTER LINK PTE LTD | Singapore | 1 | $612.94 | SANITAS MEDTECH INST… | Tablet |
| 20 | TEVA PHARMACEUTICALS USA INC | United States | 2 | $426.97 | WATSON PHARMA PVT LTD | Tablet |
| 21 | ELTON TATENDA GUWU | South Africa | 1 | $257.51 | HANSI TRADERS | Injection |
| 22 | REGENCY EXIM TRADE LTD | Mauritius | 2 | $28.51 | SAVA HEALTHCARE LTD | Tablet |
| 23 | EMIRATES POST GROUP | United Arab Emirates | 4 | $22.47 | MOVID IMPEX | Tablet |
| 24 | SEQUENCE MEDICARE SDN BHD | Malaysia | 2 | $22.17 | MERCURY MEDICARE | Tablet |
| 25 | HEALTH CITY CAYMAN ISLANDS (HCCI) | Cayman Islands | 1 | $19.76 | NARAYANA HRUDAYALAYA… | Tablet |
| 26 | CAREWELL PHARMACY (PTY)LTD | Seychelles | 2 | $18.33 | CHEMSELECT PVT LTD | retard capsule, Tablet |
| 27 | TREE TOP HEALTH PVT LTD | Maldives | 3 | $10.37 | MEDICARE PHARMA | Tablet, Syrup |
| 28 | CENTRAL POINT PHARMACY | Seychelles | 3 | $10.22 | NALIINI.R.EXPORT PVT… | retard, retard capsule, Other |
| 29 | APOTEX INC | Canada | 3 | $4.79 | APOTEX RESEARCH PVT … | Tablet |
| 30 | THE MASTER OF ECO TRAMONTANE | Panama | 1 | $3.11 | 3CUBE MEDICARE PVT LTD | Tablet |
| 31 | THE MASTER OF X PRESS GODAVARI | Netherlands | 1 | $2.68 | 3CUBE MEDICARE PVT LTD | Tablet |
| 32 | THE MASTER OF X PRESS MULHACEN | Netherlands | 1 | $2.28 | 3CUBE MEDICARE PVT LTD | Tablet |
| 33 | BULLSEYE PHARMACY | Dominica | 1 | $0.423 | AASHIRWAD PHARMA INT… | retard tablet |
This report covers 104 2025-Q4 Theophylline shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/theophylline
Talk to our trade analyst
Need a custom theophylline report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/theophylline
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Theophylline product page
Live data, supplier directory, price trends, and trade route analysis